title: New direction for glaucoma therapeutics: focus on the olfactomedin domain of myocilin.
authors.forename: Rebecca K
authors.initials: RK
authors.lastname: Donegan
authors.forename: Raquel L
authors.initials: RL
authors.lastname: Lieberman
mesh_terms: D003598:Cytoskeletal Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000737:chemistry; D005123:Eye / Q000187:drug effects / Q000378:metabolism; D005136:Eye Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D005901:Glaucoma / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D006023:Glycoproteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D009154:Mutation; D017434:Protein Structure, Tertiary; D000099179:Myocilin
chemical_list: D003598:Cytoskeletal Proteins; D016326:Extracellular Matrix Proteins; D005136:Eye Proteins; D006023:Glycoproteins; D000099179:Myocilin; C081451:olfactomedin